14 Mar 2023 Oxurion provides update on recruitment for KALAHARI Phase 2, Part B trial of novel PKal inhibitor THR-149 in diabetic macular edema and announces Board changes Member news
09 Feb 2023 Launch of Biotope Ventures empowers young biotech startups in the biotope by VIB program Member news
13 Jan 2023 Ziphius Vaccines appoints former head of Janssen Vaccines R&D as Chief Scientific Advisor Member news
09 Jan 2023 Foundational RNA and cLNP expert Antonin (Tony) de Fougerolles joins eTheRNA as independent board member Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
